Company Summary

1200 Pharma uses breakthrough medicinal chemistry technology from Caltech and proprietary biomarker-driven assays from UCLA to dramatically accelerate pre-clinical drug discovery and clinical approval timelines.

Year Founded:  2017

Key Executives:
David Licata, CEO

Location:  Pasadena, CA

Company Status:  Private

Year Invested:  2017

Investment Status:  Current

Board Members:
Paul Becker (Observer)